Suraksha Diagnostic Limited (BOM:544293)

Market Cap	16.97B +3.6%
Revenue (ttm)	3.25B +23.3%
Net Income	357.98M +7.6%
EPS	6.88 +9.5%
Shares Out	n/a
PE Ratio	47.40
Forward PE	42.21
Dividend	0.50 (0.16%)
Ex-Dividend Date	Sep 15, 2026

Volume	11,942
Open	306.15
Previous Close	304.90
Day's Range	304.95 - 329.20
52-Week Range	224.10 - 333.65
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Suraksha Diagnostic

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company al...

• Industry: Medical Laboratories
• Founded: 1992
• Employees: 1,300
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544293

Financial Performance

In fiscal year 2026, Suraksha Diagnostic's revenue was 3.10 billion, an increase of 23.13% compared to the previous year's 2.52 billion. Earnings were 321.87 million, an increase of 1.14%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 22, 2026

Data Sources Report a data error